Hepatitis B vaccine recombinant - Changchun huapu biological technique/Zhejiang Provincial Center for Disease Control and Prevention
Latest Information Update: 28 Dec 2019
At a glance
- Originator Changchun huapu biological technique; Zhejiang Provincial Center for Disease Control and Prevention
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for phase-I development in Hepatitis-B(Prevention, In volunteers) in China (Parenteral)
- 11 Jun 2017 Changchun huapu biological technique completes a phase I trial in Hepatitis B (In volunteers, Prevention) in China (ChiCTR-IIR16009836)
- 12 Nov 2016 Phase-I clinical trials in Hepatitis B (In volunteers, Prevention) in China (Parenteral)